Specifically, high attained dose was associated with lower: all-cause mortality (RR = 0.42, P 25% group, with a mean patient-level change of 0.2% versus 0.8% relative to the pre-treatment baseline measurement ( P 25% weight loss group (126 mmHg versus 13 mmHg, P 25% weight loss group (75.4 mmHg versus 78.0 mmHg) and progressively larger patient-level declines relative to baseline across the different weight loss strata ( P = 0.002
For a lot of people, that amount of money stacks up to rent, childcare, or other essential costs of living, which puts the luxury of pharmaceutical weight loss under the microscope
To view or add a comment, sign in NAMs are asked to outperform animal data
Repeated shots in the same spot can scar or harden fatty tissue, which may or may not interfere with absorption
8.6 Scientific integrity and responsible framing From a scientific-integrity standpoint, the renewed interest in underexplored peptide systems carries an obligation to avoid overstated claims and selective citation